DK0484581T3 - Anvendelse af thromboxan-A2-receptorantagonister til forhindring af degenerative processer i det penile væv - Google Patents

Anvendelse af thromboxan-A2-receptorantagonister til forhindring af degenerative processer i det penile væv

Info

Publication number
DK0484581T3
DK0484581T3 DK90121343.9T DK90121343T DK0484581T3 DK 0484581 T3 DK0484581 T3 DK 0484581T3 DK 90121343 T DK90121343 T DK 90121343T DK 0484581 T3 DK0484581 T3 DK 0484581T3
Authority
DK
Denmark
Prior art keywords
receptor antagonists
thromboxane
penile tissue
degenerative processes
prevent degenerative
Prior art date
Application number
DK90121343.9T
Other languages
English (en)
Inventor
Johannes Dr Rer Nat Dr Me Pill
Klaus-Peter Dr Juenemann
Johannes Dr Aufenanger
Thomas Dr Konrad
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of DK0484581T3 publication Critical patent/DK0484581T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90121343.9T 1990-11-08 1990-11-08 Anvendelse af thromboxan-A2-receptorantagonister til forhindring af degenerative processer i det penile væv DK0484581T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90121343A EP0484581B1 (de) 1990-11-08 1990-11-08 Verwendung von Thromboxan-A2-Antagonisten zur Verhinderung von degenerativen Vorgängen im penilen Gewebe
CA002076005A CA2076005A1 (en) 1990-11-08 1990-12-22 Use of thromboxane-a2-receptor antagonists for the prevention of reduction of degenerative process in the penile tissue

Publications (1)

Publication Number Publication Date
DK0484581T3 true DK0484581T3 (da) 1994-10-24

Family

ID=25675428

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90121343.9T DK0484581T3 (da) 1990-11-08 1990-11-08 Anvendelse af thromboxan-A2-receptorantagonister til forhindring af degenerative processer i det penile væv

Country Status (8)

Country Link
US (1) US5192806A (da)
EP (1) EP0484581B1 (da)
AT (1) ATE107164T1 (da)
CA (1) CA2076005A1 (da)
DE (1) DE59006158D1 (da)
DK (1) DK0484581T3 (da)
ES (1) ES2056337T3 (da)
WO (1) WO1992011005A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用

Also Published As

Publication number Publication date
CA2076005A1 (en) 1992-06-23
WO1992011005A1 (de) 1992-07-09
EP0484581B1 (de) 1994-06-15
EP0484581A1 (de) 1992-05-13
US5192806A (en) 1993-03-09
DE59006158D1 (de) 1994-07-21
ES2056337T3 (es) 1994-10-01
ATE107164T1 (de) 1994-07-15

Similar Documents

Publication Publication Date Title
CL2003002756A1 (es) Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia.
ES2128735T3 (es) Composiciones farmaceuticas que comprenden un antagonista de opiaceos y de sales de calcio y su uso para el tratamiento de patologias en las que intervienen las endorfinas.
FI980822A7 (fi) Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi
DE68903846D1 (de) Neue galenische form von fenofibrat.
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
ATE114151T1 (de) Benzocyclobutyl- oder indanyl-alkyl-amino-alkyl substituierte 3-benzazepin-2-ones, verwendbar in der behandlung von kardiovaskularen krankheiten.
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
PT100514A (pt) 3-aminoquinuclidinas substituidas e composicoes farmaceuticas que qs contem
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
ECSP941122A (es) Derivados de 5-arilindoles
DE69432984D1 (de) Therapeutische substituierte guanidine
AR025883A1 (es) Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos
CY1105125T1 (el) Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
ES2046500T3 (es) Derivado de la histamina, su preparacion y su aplicacion en terapeutica.
DK0474712T3 (da) Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
IT1247796B (it) Derivati arilvinilamidici e procedimento per la loro preparazione
DK0484581T3 (da) Anvendelse af thromboxan-A2-receptorantagonister til forhindring af degenerative processer i det penile væv
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica